One on One DIA 2021 - Clinical Ink (Ed Seguine)
Thought Leader:
Ed Seguine, CEO, Clinical Ink
Ed Seguine identifies areas of importance to consider when thinking about patients and sites in totality as well as how technology can support complex protocol design.